This message was sent to ##Email##
#ADAA2019 Program Spotlight
The 39th annual ADAA conference offers 160+ sessions on a wide range of topics that will offer a total of 29.5 CE/CME credits! CE registration is free for ADAA members, so be sure to register today. Hotel rooms are still available at the Sheraton Grand.
Our “Not-To-Miss” Invited Sessions!
Check out the #ADAA2019 Special Events Webpage for all of the exciting activities and events going on throughout the conference:
Meet the #ADAA2019 Awardees!
- Free Professional Headshots
- Welcome Reception and Exhibit Hall Grand Opening
- Breakfast for First-Time Attendees
- Special Genetics and Neuroscience Special Interest Group Program
- Early Career Professionals and Students Lunch – and Special Program Meeting
- Children and Adolescent Special Interest Group Special Program
- The ADAA SurPRIZE Squad (you just might win a fun gift!)
- Friday evening Dine-Arounds – still time to sign up!
- Off-Site Event: Therapy Players - Chicago’s Premier All-Psychotherapist Comedy Improve Troupe
Since its inception in 1998, the ADAA awards program has provided more than one million dollars to 500 aspiring professionals and given them access to a professional home, unique pairings with senior mentors from our membership, and participation at the 2019 annual conference. Learn more about the ADAA awards programs here.
The 2019 ADAA awards program is sponsored by AMITA Health.
Bring a Book to #ADAA2019 for Bhutan!
Dr. Karen Cassiday, ADAA Past President, is volunteering in Bhutan at the Jigme Dorji Wangchuck National Referral Hospital and in the Department of Psychiatry at the Khesar Gyalp University of Medical Sciences this June through September 2019. The national referral hospital and medical university are small and in need of psychiatry and behavioral health textbooks and self-help books. You can have a powerful positive impact by donating books at #ADAA2019 that Dr. Cassiday can bring with her to Bhutan. Look for signage in the Registration area. Many thanks on behalf of Dr. Cassiday and ADAA.
Thank you to ADAA's Current #ADAA2019 Sponsors
Rogers Behavioral Health
American Foundation for Suicide Prevention
Houston OCD Program
Janssen Research and Development LLC
Barn Life Recovery
Beck Institute for Cognitive Behavioral Therapy
Massachusetts General Hospital Psychiatry Academy
Thank You to ADAA's Current #ADAA2019 Exhibitors
For details on sponsorship or exhibiting opportunities, please contact Gabby Oved at firstname.lastname@example.org or 240-485-1031.
Our clinical team recognizes the importance of long-term care for improved treatment outcomes. At The Oaks, we treat and care for the whole person - no matter where they fall on the behavioral health spectrum. The soul of what we do is in building a foundation for you and your patients to thrive.
ADAA offers a variety of webinars for mental health professionals. Most ADAA professional webinars offer CE/CME and AWSB credits.
Wednesday, April 10, 2019 — Dean McKay, PhD, ABPP presents:
An Old Approach with a New Twist: Applications of Inhibitory Learning in Exposure Therapy
Eligible for 1 CE/CME hour
Wednesday, May 8, 2019 – Debra Kissen, PhD, MHSA, Lynne Siqueland, PhD and Ruth Lippin, LCSW, JD present:
Collaborating with Pediatricians: Tools & Techniques to Enhance Relationships & Care Coordination with Pediatricians in your Community
Eligible for 1 CE/CME Hour
Thursday, June 13, 2019 — David Rosmarin, PhD, ABPP presents:
Spirituality & Mental Health: What Clinicians Need to Know
Eligible for 1 CE/CME hour
Based on member survey requests for more interactive educational initiatives, the Public Education Committee is pleased to announce our first online interactive Fall Forum which will address understanding and treating maternal anxiety and depression. The three-hour conversation will include discussions on the following topics:
Stay tuned for date/time and more details..
- Medications for maternal mental health issues
- Medication complexities during pregnancy and nursing
- Challenges associated with mood/anxiety across pregnancy and motherhood
- Maternal MH screening in pregnancy, post-partum, and infant visits
- Psychotherapy interventions for maternal MH issues
Recent ADAA Recordings
Click here for a full listing of all on-demand webinars.
Michael J. Kozak, PhD
Dr. Michael Kozak, a long-time ADAA member, mentor, conference presenter and supporter, passed away last week. Dr. Kozak’s work and research were focused on understanding and treating anxiety and related conditions and he is considered to be a pioneer in the field of OCD. Dr. Kozak earned his A.B. in psychology from the University of Pennsylvania, where he studied animal learned helplessness, and his M.S. and Ph.D. in clinical psychology from the University of Wisconsin- Madison, where he studied the psychophysiology of emotional imagery. He has studied process and outcome of psychotherapy and pharmacotherapy for anxiety, including blood/injury phobia, obsessive-compulsive disorder, post-traumatic stress disorder, and social anxiety. His scholarly publications include case studies and controlled treatment trials, psychophysiological assessments, theoretical and review articles, and philosophical analyses. His manual for exposure-based treatment, Mastery of Obsessive-Compulsive Disorder, co-authored with longtime ADAA member Dr. Edna Foa, has been translated into German and Norwegian. Dr. Kozak’s devotion to and passion for his work will be much missed by those who had the honor of knowing and collaborating with him.
“Michael was a very close collaborator for 19 years. His extraordinary conceptual ability has greatly influenced my theoretical and empirical work to this day.” — Edna B. Foa, PhD – ADAA Member
“The world of psychology will remember the footprints you left, and the generations to come will carry the bright torch that you lit. I will always remember your clarity, wisdom, and intelligence, and I will carry our memories from our quarter of a century friendship in my heart always." — Eda Gorbis, PhD, LMFT – ADAA Member
ADAA is proud to showcase the cutting-edge research conducted by our members. If you are interested in featuring your research lab, please download the flyer here or contact Astrid Masfar: email@example.com
New ADAA Member Blog Post
Avoid the Snake Oil: Pseudoscience and OCD Treatment
by Katie D. Kriegshauser, PhD
Have you been quoted in a recent news article/story? Please let us know so we can share your news with your ADAA colleagues and with our public community (here, through the website and via our social media platforms).
April 2019, Keep Calm and Recycle On, The Oprah Magazine, Karen Cassiday, PhD and Lata K. McGinn, PhD
03/21/2019 Helen Odessky, PsyD – “Stop Anxiety from Stopping You”, Defeating Depression POD, Helen Odessky, PsyD
03/21/2019 How Spring Cleaning Can Help Manage Stress, According to Psychologists, GoodHouseKeeping.com, Alicia Clark, PsyD
03/20/2019 Do Dates Care About Your Messy Room? Here's How To Handle The Situation, EliteDaily.com, Lata McGinn, PhD
03/20/2019 LI Women Part of Clinical Trials for Drug Approved to Treat Postpartum Depression, Newsday.com, Kristina Deligiannidis, MD
03/20/2019 “Everything is Awful!” How To Deal With Negativity In Teens, YourTeenMag.com, Mary Alvord, PhD
03/20/2019 FDA Approves First Postpartum Depression Drug, CNN.com, Kristina M. Deligiannidis MD
03/19/2019 Sage Gets U.S. Approval For First Postpartum Depression Therapy, KFGO.com, Sanjay Mathew, MD
03/19/2019 FDA Approves First Postpartum Depression Drug, WGNTV.com, Kristina M. Deligiannidis MD
03/19/2019 Postpartum Depression Drug Given Historic Approval by FDA, CBSLocalDenver.com, Kristina M. Deligiannidis, MD
03/19/2019 Faster and Easier Approaches for Improving Patients' Depression Treatment Outcomes, CareForYourMind.org, Michael Thase, MD
03/18/2019 Teen Suicides are on the Rise. Here’s What Parents can do to Slow the Trend, WashingtonPost.com, Mary Alvord, PhD
03/15/2019 Why We Dread Bedtime When We're Anxious, FutureofPersonalHealth.com, Joseph Brand, PhD
03/14/2019 5 Anxiety Symptoms in Men, MensHealth.com, Stefan G. Hofmann, PhD
03/13/2019 Mobile Phone Technology to Screen, Help Treat College Students, Medicine.Wustl.edu, Michelle Newman, PhD
03/12/2019 New Way to Combat Childhood Anxiety: Treat the Parents, News.Yale.Edu, Eli Lebowitz, PhD and Wendy Silverman, PhD
03/10/2019 How to Help Your Child During College-Acceptance Season, SantaFeNewMexican.com, Mary Alvord, PhD
03/07/2019 The Many Obsessions That Can Haunt a Person with OCD, Tonic.Vice.com, Jon Hershfield, MA, LMFT
Member Research News
Parent-Based Treatment as Efficacious as Cognitive Behavioral Therapy for Childhood Anxiety: A Randomized Noninferiority Study of Supportive Parenting for Anxious Childhood Emotions, March 6, 2019, Journal of the American Academy of Child and Adolescent Psychiatry, by Eli R. Lebowitz, PhD, Carla Marin, PhD, Alyssa Martino, MA, Yaara Shimshoni, PhD, Wendy K. Silverman, PhD
Member Publication News
Overcoming Unwanted Intrusive Thoughts: A CBT-Based Guide to Getting Over Frightening, Obsessive, or Disturbing Thoughts, by Sally M.Winston, PsyD and Martin N Seif, PhD has been selected as an Association for Behavioral and Cognitive Therapies Self-Help Book Recommendation - an honor bestowed on outstanding self-help books that are consistent with cognitive behavioral therapy (CBT) principles and that incorporate scientifically tested strategies for overcoming mental health difficulties.
Have you published a new book for consumers or professionals? Please let us know so we can highlight your new publication here and on the ADAA website.
ADAA is also interested in highlighting our members' research. Please send us your recent research news for us to post and share.
March 2019 Issue — Volume 36, Issue 3
FOCUS ON: TREATMENTS FOR DEPRESSION AND ANXIETY
Early View Articles:
Trajectories of childhood adversity and the risk of depression in young adulthood: Results from the Avon Longitudinal Study of Parents and Children
Melissa Tracy, Madeleine Salo, Natalie Slopen, Tomoko Udo, Allison A. Appleton
Version of Record online: 18 March 2019
Clinical risk factors among youth at high risk for suicide in South Africa and Guyana
Veronica J. Thornton, Comfort B. Asanbe, Ellen‐ge D. Denton
Version of Record online: 21 March 2019
Resting‐state amplitude of low‐frequency fluctuation is associated with suicidal ideation
Martin J. Lan, Mina M. Rizk, Spiro P. Pantazatos, Harry Rubin‐Falcone, Jeffrey M. Miller, M. Elizabeth Sublette, Maria A. Oquendo, John G. Keilp, J. John Mann
Version of Record online: 21 March 2019
Depression and Anxiety, the official journal of the Anxiety and Depression Association of America, is available online at no charge to ADAA members. The journal welcomes original research and synthetic review articles covering neurobiology (genetics and neuroimaging), epidemiology, experimental psychopathology, and treatment (psychotherapeutic and pharmacologic) aspects of mood and anxiety disorders, and related phenomena in humans. Per the ISI Journal Citation Reports Rankings for 2017, the Depression and Anxiety impact factor is 5.043. The journal ranks 19 of 142 in psychiatry journals; 8 of 77 in psychology journals; 5 of 121 for psychology clinical journals, and 15 of 139 for psychiatry social science journals. Google Scholar psychiatry journal ranking (spring 2017) ranked Depression and Anxiety #19 of 20.
Murray B. Stein, MD, MPH - Editor-in-Chief
Meet the Journal Editorial Board
The Child Mind Institute is co-hosting a special screening of the new documentary “Suicide: The Ripple Effect” about Kevin Hines’ experiences with depression and suicide. The screening includes a special conversation between Hines and Harold Koplewicz, MD, president and founder of the Child Mind Institute.
We’d love to extend this invitation to ADAA’s New York City community.
- Date: Monday, April 8th
- Time: 1:00 pm – 3:00 pm
- Location: JCC Manhattan, 334 Amsterdam Avenue, New York, NY
- RSVP here – the event is free with our friends and family coupon of CMI19
The APA would like to share the following three HRSA grant announcements:
- $18 million for Graduate Psychology Education Program
The Health Resources and Services Administration (HRSA) is accepting applications for fiscal year (FY) 2019 for the Graduate Psychology Education (GPE) Program. The purpose of this program is to train doctoral health psychology students, interns, and post-doctoral residents to provide integrated, interdisciplinary, behavioral health and Opioid Use Disorder (OUD) and other Substance Use Disorder (SUD) prevention and treatment services in high need and high demand areas. The program also supports faculty development of health service psychology.
- $39 million for Opioid Workforce Expansion Professionals Program
The Health Resources and Services Administration (HRSA) is accepting applications for fiscal year (FY) 2019 for the Opioid Workforce Expansion Program (OWEP) Professionals program. The purpose of this Notice of Funding Opportunity (NOFO) is to build upon existing HRSA investments to enhance community-based experiential training focused on Opioid Use Disorder (OUD) and other Substance Use Disorders (SUD) for students preparing to become behavioral health professionals. The OWEP Professionals program will train behavioral health professionals in the provision of OUD and other SUD prevention, treatment, and recovery services in high need and high demand areas. Special focus is on demonstrating knowledge and understanding of the specific concerns of children, adolescents, and transitional-age youth in high need and high demand areas who are at risk for behavioral health disorders.
- $2 million for Geriatrics Academic Career Awards
HRSA has reopened the notice of funding opportunity (NOFO) for the Geriatrics Academic Career Awards (GACA) Program grant application. The purpose of the GACA program is to support the career development of individual junior faculty in geriatrics at accredited schools of allopathic medicine, osteopathic medicine, nursing, social work, psychology, dentistry, pharmacy, or allied health as academic geriatrics specialists and to provide clinical training in geriatrics, including the training of interprofessional teams of health care professionals. Eligible applicant organizations include accredited schools of allopathic medicine, osteopathic medicine, nursing, social work, psychology, dentistry, pharmacy, or allied health.
| || RESEARCH AND PRACTICE NEWS|
On March 5, the Food and Drug Administration approved the first truly new medication for major depression in decades. The drug is a nasal spray called esketamine, derived from ketamine—an anesthetic that has made waves for its surprising antidepressant effect.
Because treatment with esketamine might be so helpful to patients with treatment-resistant depression, the FDA expedited the approval process to make it more quickly available. In one study, 70 percent of patients with treatment-resistant depression who were started on an oral antidepressant and intranasal esketamine improved, compared to just over half in the group that did not receive the medication.
For the first time in history, the U.S. Food and Drug Administration has approved a drug specifically indicated for the treatment of postpartum depression, which experts say offers new hope to women and physicians.
The FDA announced the approval of an intravenous infusion of the drug brexanolone, which will be sold as Zulresso. It has been shown in clinical trials to work within hours to treat the symptoms of postpartum depression, a serious mental illness that impacts one in nine new mothers after childbirth.
Yale researchers have developed an innovative way to address an epidemic of anxiety disorders afflicting the nation’s children: treat the parents.
A new program developed at Yale that counsels parents is as effective in treating common anxiety disorders as cognitive behavioral therapy for the child, according to a randomized trial of the two therapies published in the Journal of the American Academy of Childhood and Adolescent Psychiatry.
Major depression, serious psychological distress and other mental health issues have been on the rise in teenagers and young adults over the past decade, according to recently published research in the Journal of Abnormal Psychology. "More U.S. adolescents and young adults in the late 2010s, versus the mid-2000s, experienced serious psychological distress, major depression or suicidal thoughts, and more attempted suicide,” lead author Jean Twenge said in a statement. “These trends are weak or non-existent among adults 26 years and over, suggesting a generational shift in mood disorders instead of an overall increase across all ages."
Task & Purpose
The newest FDA-approved medication to treat severe depression, a nasal spray based on the anesthetic (and misused hallucinogenic party drug) ketamine, will soon be available to veterans treated within the Department of Veterans Affairs.
In a move that may help thousands of former service members with depression that has not improved with other treatments, VA officials announced that the department's doctors are now authorized to prescribe Spravato, the brand name for esketamine, a molecular variation of ketamine.
Wiley via ScienceDaily
In an Addiction analysis of relevant published studies, investigators found some evidence for a positive association between anxiety during childhood and adolescence with later alcohol use disorders. The authors of the analysis noted that it is important to establish which anxious individuals consume more alcohol and develop alcohol use disorders in order to develop targeted interventions.
A study of over a hundred people’s brains suggests that abuse during childhood is linked to changes in brain structure that may make depression more severe in later life.
Nils Opel at the University of Münster, Germany, and his colleagues scanned the brains of 110 adults hospitalised for major depressive disorder and asked them about the severity of their depression and whether they had experienced neglect or emotional, sexual or physical abuse during childhood.
A new large-scale longitudinal study carried out by University of Sussex psychologists has found a clear link between episodes of depression and anxiety experienced by adults in their twenties, thirties and forties with a decrease in memory function by the time they are in their fifties. The study, published in the British Journal of Psychiatry, is the first of its kind to look at the relationship between depressive symptoms experienced across three decades of early-mid adulthood and a decline in cognitive function in midlife.
Medical News Today
Researchers already recognized the link between depression and heart disease. However, until recently, the mechanisms explaining it remained a mystery. A new study reveals that stress-induced inflammation may explain why mental and cardiovascular health are so intimately related.
University of New South Wales via Medical Xpress
A new interactive website launched by UNSW mental health researchers allows people with a family history of major depressive or bipolar disorder to work out how likely it is that they – or any of their offspring – could develop these mental illnesses.
And according to the research article published in BMC Psychiatry, which reported on a trial of this website with 202 participants, this new psychoeducational tool fills a gap in knowledge that is unmet by existing online interventions.
Low field magnetic stimulation has mood enhancing effects in treatment-resistant depression that accrue with multiple doses, according to study results published in the Journal of Affective Disorders.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063